RADIANCE: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia
10.1016/j.ophtha.2013.10.023
Saved in:
Main Authors: | Wolf, S., Balciuniene, V.J., Laganovska, G., Menchini, U., Ohno-Matsui, K., Sharma, T., Wong, T.Y., Silva, R., Pilz, S., Gekkieva, M. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/128642 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Choroidal neovascularization in pathological myopia
by: Neelam, K., et al.
Published: (2014) -
Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: An evidence-based systematic review
by: Wong, T.Y., et al.
Published: (2014) -
Dramatic resolution of choroidal neovascular abnormalities after single aflibercept injection following years of ranibizumab use
by: Chaikitmongkol V., et al.
Published: (2014) -
Choroidal thickness and risk characteristics of eyes with myopic choroidal neovascularization
by: Cheung, C.M.G., et al.
Published: (2014) -
Choroidal neovascularization : mechanisms of endothelial dysfunction
by: Yeo, Natalie Jia Ying, et al.
Published: (2021)